Seroprevalence of herpes simplex virus types 1 and 2-United States, 1999-2010

Journal of Infectious Diseases

Volumn 209, Issue 3, 2014, Pages 325-333

  Bradley, Heather ^a   Markowitz, Lauri E ^a   Gibson, Theda ^b   McQuillan, Geraldine M ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

adolescents; genital herpes; herpes simplex virus; HSV 1; HSV 2; NHANES

Indexed keywords

ADOLESCENTS; GENITAL HERPES; HERPES SIMPLEX VIRUS; HSV-1; HSV-2; NHANES;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84892655914     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit458     Document Type: Article

References (27)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-73.
2. Corey L, Wald A. Genital herpes. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw Hill, 2008:399-438.
3. Freeman EE, Weiss HA, Glynn JR., Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
4. Gray RH, Li X, Wawer MJ, et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. J Infect Dis 2004; 189:1209-15.
5. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. New Engl J Med 2002; 347:1652-61.
6. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. New Engl J Med 2012; 366:34-43.
7. Wald A. Genital HSV-1 infections. Sex Transm Infect 2006; 82:189-90.
8. Roberts CM, Pfister JR., Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30:797-800.
9. Bernstein DI, Bellamy AR, Hook EW III, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013; 56:344-51.
10. Samra Z, Scherf E, Dan M. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Sex Transm Dis 2003; 30:794-6.
11. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Increasing role of herpes simplex virus type 1 in first episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect 2009; 85:416-9.
12. Gilbert M, Li X, Petric M, et al. Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can J Public Health 2011; 102:225-9.
13. Lee FK, Coleman RM, Pereira L, Griffin C, Reid E, Nahmias A. Detection of herpes simplex virus type-2-specific antibody with glycoprotein G. J Clin Microbiol 1985; 22:641-4.
14. Lee FK, Pereira L, Griffin C, Reid E, Nahmias A. A novel glycoprotein (gG-1) for detection of herpes simplex virus specific antibodies. J Virol Methods 1986; 14:111-8.
15. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus type 1 and type 2 in human sera. J Clin Microbiol 1988; 26:662-7.
16. Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 1991; 81:1166-73.
17. National Center for Health Statistics. Design and estimation for the National Health Interview Survey, 1995-2004. Vital Health Statistics 2000; 130:1-31.
18. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. New Engl J Med 1997; 337:1105-11.
19. Sauerbrei A, Schmitt S, Scheper T, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Euro Surveill 2011; 16:1-7.
20. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004; 80:185-91.
21. Aarnisalo J, Ilonen J, Vainionpää R, Volanen I, Kaitosaari T, Simell O. Development of antibodies against cytomegalovirus, varicella-zoster virus and herpes simplex virus in Finland during the first eight years of life: a prospective study. Scand J Infect Dis 2003; 35:750-3.
22. Vyse AJ, Gay NJ, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76: 183-7.
23. Schillinger JA, Xu F, Sternberg MJ, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis 2004; 31:753-60.
24. Pouget ER, Kershaw TS, Blankenship KM, Ickovics JR., Niccolai LM. Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2. Sex Transm Dis 2010; 37:538-43.
25. Centers for Disease Control and Prevention. Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2006-2010 National Survey of Family Growth. Vital Health Stat 2011; 23:1-35.
26. Copen CE, Chandra A, Martinez G. Prevalence and timing of oral sex with opposite-sex partners among females and males aged 15-24 years: United States, 2007-2010. National Health Statistics Reports; 2012; No. 56. Hyattsville, MD: National Center for Health Statistics.
27. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE; Chiron HSV Vaccine Study Group. A prospective study of new infections with herpes simplex virus type 1 and type 2. New Engl J Med 1999; 341:1432-8.